The AECOM/AECC Data Safety monitoring plan establishes implementation plans for the policies set forth by the National Cancer Institute in the document entitled """"""""Policy of the National Cancer Institute for Data and Safety Monitoring of Clinical Trials"""""""" (http://cancertrials.nci.nih.gov/clinicaltrials/conductinq/dsm-auidelines/paae2V These policies pertain to the monitoring of all clinical trials supported by NCI, and thus encompass all NCI funded clinical trials, intramural, multicenter and cooperative group. The policies and procedures for Data and Safety Monitoring of the clinical research programs at the AECC are established and monitored by the Protocol Review and Monitoring Committee and the Cancer Center Clinical Research Executive Committee. The Data Safety Monitoring Committee is a major component of the Cancer Center and reports directly to the head of the Protocol Review and Monitoring Committee, the CPDMU, the Cancer Center Director and the AECOM/Montefiore IRBs. The document includes the major functions and responsibilities of data and safety monitoring of our active clinical trials program(s) and includes a detailed description of the following: Individual responsible for monitoring The frequency of the review A description of what is being monitored The procedures for different classes of clinical trials The evaluation and investigator feedback/communication process The procedures for managing and averting conflicts of interest Adverse event procedures Suspensions of clinical trials Protocol compliance auditing procedures The Data Safety Monitoring Committee (DSMC) has the responsibility for ensuring data and safety monitoring along with each of the protocol Principal Investigators who are ultimately responsible for the ongoing monitoring and safety of clinical protocols. The DSMC is comprised of investigators from throughout the College and Cancer Center, and have a variety of different expertise. Dr. Richard Gorlick chairs the DSMC. The remainder of the membership is listed in the table below. The DSMC is provided with administrative support, database management, etc., by the CPDMU. The DSMC meeting occurs immediately prior to the PRMC meeting to ensure immediate transmission of information. Representatives of the CCI and PRMC serve in a non-voting capacity on the DSMC to assure communication.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013330-40
Application #
8582107
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-06-01
Project End
2018-06-30
Budget Start
2013-08-23
Budget End
2014-06-30
Support Year
40
Fiscal Year
2013
Total Cost
$169,185
Indirect Cost
$51,766
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Ruiz, Penelope D; Gamble, Matthew J (2018) MacroH2A1 chromatin specification requires its docking domain and acetylation of H2B lysine 20. Nat Commun 9:5143
Rohan, Thomas; Ye, Kenny; Wang, Yihong et al. (2018) MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 13:e0191814
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150

Showing the most recent 10 out of 1508 publications